Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 1 1

Status

Completed 56Active not recruiting 16Recruiting 12Terminated 5Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 26INDUSTRY 5NIH 1NETWORK 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 5Gynecologic 1

Conditions

Breast Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Patient Compliance 1Ovarian Neoplasms 1Endometrial Neoplasms 1Breast Cancer Metastatic 1

Interventions

pembrolizumab 184Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 54fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 40Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Anastrozole × Clear all
NCT04059484 2026-02-24

AMEERA-3

Sanofi

Phase 2 Terminated
367 enrolled 30 charts
Breast

Breast Cancer Metastatic

NCT03220178 2022-01-06

PRECYCLE

Palleos Healthcare GmbH

Phase 4 Terminated
532 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02476955 2020-09-30

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

Phase 1 Terminated
41 enrolled
BreastGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT01151215 2014-07-25

MINT

AstraZeneca

Phase 2 Terminated
482 enrolled 10 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00555867 2011-12-23

PACT

AstraZeneca

Terminated
4,923 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡